Background Device closure of atrial septal defect (ASD) and patent foramen ovale (PFO) are
both associated with short‐and long‐term complications. Our knowledge of the complication …

Background and Purpose—Patients discovered to have a patent foramen ovale in the
setting of a cryptogenic stroke may be treated with percutaneous closure, antiplatelet …

Objectives: In this study, a meta-analysis of observational studies was performed to compare
the rate of recurrent neurological events (RNE) between transcatheter closure and medical …

We have conducted a systematic review of air embolism complications of neurosurgery in
the sitting position and patent foramen ovale (PFO) closure. It assesses the risk and benefit …

Background: Among patients with a patent foramen ovale (PFO) and a prior cryptogenic
ischemic stroke or TIA, the absolute and relative risk of recurrent events is unclear. Methods …

Importance Patent foramen ovale (PFO) closure may prevent recurrent stroke after
cryptogenic transient ischemic attack (TIA) or stroke (TIA/stroke) in patients aged 60 years or …

Objectives The aim of this study was to investigate the effect of management on the risk for
recurrent events among patients with cryptogenic ischemic stroke or transient ischemic …

Objectives: This study sought to identify predictors of recurrent ischemic neurologic events
within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a …

Context The role of percutaneous closure of patent foramen oval (PFO) in patients with
cryptogenic stroke has been very controversial for years due to a lack of clear evidence …

Health technology assessment (HTA) of medical devices (MDs) increasingly rely on real‐
world evidence (RWE). The aim of this study was to evaluate the type and the quality of the …